124 related articles for article (PubMed ID: 34742136)
1. One year of omega 3 polyunsaturated fatty acid supplementation does not reduce circulating prothrombotic microvesicles in elderly subjects after suffering a myocardial infarction.
Chiva-Blanch G; Bratseth V; Laake K; Arnesen H; Solheim S; Schmidt EB; Badimon L; Seljeflot I
Clin Nutr; 2021 Dec; 40(12):5674-5677. PubMed ID: 34742136
[TBL] [Abstract][Full Text] [Related]
2. Effects of ω3 supplementation in elderly patients with acute myocardial infarction: design of a prospective randomized placebo controlled study.
Laake K; Myhre P; Nordby LM; Seljeflot I; Abdelnoor M; Smith P; Tveit A; Arnesen H; Solheim S
BMC Geriatr; 2014 Jun; 14():74. PubMed ID: 24928284
[TBL] [Abstract][Full Text] [Related]
3. Effects of n-3 Fatty Acid Supplements in Elderly Patients After Myocardial Infarction: A Randomized, Controlled Trial.
Kalstad AA; Myhre PL; Laake K; Tveit SH; Schmidt EB; Smith P; Nilsen DWT; Tveit A; Fagerland MW; Solheim S; Seljeflot I; Arnesen H;
Circulation; 2021 Feb; 143(6):528-539. PubMed ID: 33191772
[TBL] [Abstract][Full Text] [Related]
4. The Mediterranean diet decreases prothrombotic microvesicle release in asymptomatic individuals at high cardiovascular risk.
Chiva-Blanch G; Sala-Vila A; Crespo J; Ros E; Estruch R; Badimon L
Clin Nutr; 2020 Nov; 39(11):3377-3384. PubMed ID: 32147198
[TBL] [Abstract][Full Text] [Related]
5. Ageing enhances the shedding of splenocyte microvesicles with endothelial pro-senescent effect that is prevented by a short-term intake of omega-3 PUFA EPA:DHA 6:1.
Qureshi AW; Altamimy R; El Habhab A; El Itawi H; Farooq MA; Zobairi F; Hasan H; Amoura L; Kassem M; Auger C; Schini-Kerth V; Toti F
Biochem Pharmacol; 2020 Mar; 173():113734. PubMed ID: 31811867
[TBL] [Abstract][Full Text] [Related]
6. Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.
de Borst MH; Baia LC; Hoogeveen EK; Giltay EJ; Navis G; Bakker SJL; Geleijnse JM; Kromhout D; Soedamah-Muthu SS
Nutrients; 2017 Nov; 9(11):. PubMed ID: 29137111
[TBL] [Abstract][Full Text] [Related]
7. High Adherence to the Nordic Diet Is Associated with Lower Levels of Total and Platelet-Derived Circulating Microvesicles in a Norwegian Population.
Chiva-Blanch G; Laake K; Myhre P; Bratseth V; Arnesen H; Solheim S; Badimon L; Seljeflot I
Nutrients; 2019 May; 11(5):. PubMed ID: 31109111
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial.
Myhre PL; Berge T; Kalstad AA; Tveit SH; Laake K; Schmidt EB; Solheim S; Arnesen H; Seljeflot I; Tveit A
Clin Nutr; 2023 Sep; 42(9):1657-1660. PubMed ID: 37515843
[TBL] [Abstract][Full Text] [Related]
9. Dietary and Circulating Long-Chain Omega-3 Polyunsaturated Fatty Acids and Mortality Risk After Myocardial Infarction: A Long-Term Follow-Up of the Alpha Omega Cohort.
Pertiwi K; Küpers LK; de Goede J; Zock PL; Kromhout D; Geleijnse JM
J Am Heart Assoc; 2021 Dec; 10(23):e022617. PubMed ID: 34845924
[TBL] [Abstract][Full Text] [Related]
10. Platelet-, monocyte-derived and tissue factor-carrying circulating microparticles are related to acute myocardial infarction severity.
Chiva-Blanch G; Laake K; Myhre P; Bratseth V; Arnesen H; Solheim S; Badimon L; Seljeflot I
PLoS One; 2017; 12(2):e0172558. PubMed ID: 28207887
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte telomere length and serum polyunsaturated fatty acids, dietary habits, cardiovascular risk factors and features of myocardial infarction in elderly patients.
Kalstad AA; Tveit S; Myhre PL; Laake K; Opstad TB; Tveit A; Schmidt EB; Solheim S; Arnesen H; Seljeflot I
BMC Geriatr; 2019 Dec; 19(1):376. PubMed ID: 31881852
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 polyunsaturated fatty acid supplementation improves lipid metabolism and endothelial function by providing a beneficial eicosanoid-pattern in patients with acute myocardial infarction: A randomized, controlled trial.
Yuan M; Zhang Y; Hua T; Liu XL; Liu T; Yuan RY; Li GP; Zhu Y; Zhang X
Clin Nutr; 2021 Feb; 40(2):445-459. PubMed ID: 33041091
[TBL] [Abstract][Full Text] [Related]
13. Changes in lipoprotein particle subclasses, standard lipids, and apolipoproteins after supplementation with n-3 or n-6 PUFAs in abdominal obesity: A randomized double-blind crossover study.
Grytten E; Laupsa-Borge J; Bohov P; Bjørndal B; Strand E; Skorve J; Nordrehaug JE; Berge RK; Rostrup E; Mellgren G; Dankel SN; Nygård OK
Clin Nutr; 2021 May; 40(5):2556-2575. PubMed ID: 33933722
[TBL] [Abstract][Full Text] [Related]
14. n-3 fatty acids and cardiovascular events after myocardial infarction.
Kromhout D; Giltay EJ; Geleijnse JM;
N Engl J Med; 2010 Nov; 363(21):2015-26. PubMed ID: 20929341
[TBL] [Abstract][Full Text] [Related]
15. CD142+/CD61+, CD146+ and CD45+ microparticles predict cardiovascular events in high risk patients following a Mediterranean diet supplemented with nuts.
Chiva-Blanch G; Crespo J; Suades R; Arderiu G; Padro T; Vilahur G; Cubedo J; Corella D; Salas-Salvadó J; Arós F; Martínez-González MA; Ros E; Fitó M; Estruch R; Badimon L
Thromb Haemost; 2016 Jul; 116(1):103-14. PubMed ID: 27052787
[TBL] [Abstract][Full Text] [Related]
16. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
[TBL] [Abstract][Full Text] [Related]
17. Dose-dependent decrease of platelet activation and tissue factor by omega-3 polyunsaturated fatty acids in patients with advanced chronic heart failure.
Moertl D; Berger R; Hammer A; Hutuleac R; Koppensteiner R; Kopp CW; Steiner S
Thromb Haemost; 2011 Sep; 106(3):457-65. PubMed ID: 21800004
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
[TBL] [Abstract][Full Text] [Related]
19. Annexin V
Bratseth V; Margeirsdottir HD; Chiva-Blanch G; Heier M; Solheim S; Arnesen H; Dahl-Jørgensen K; Seljeflot I
J Diabetes Res; 2020; 2020():7216863. PubMed ID: 32309448
[TBL] [Abstract][Full Text] [Related]
20. Protective role of n6/n3 PUFA supplementation with varying DHA/EPA ratios against atherosclerosis in mice.
Liu L; Hu Q; Wu H; Xue Y; Cai L; Fang M; Liu Z; Yao P; Wu Y; Gong Z
J Nutr Biochem; 2016 Jun; 32():171-80. PubMed ID: 27142749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
